Ukraine talks stir Wall Street nerves

😎 Market Vibes

Monday vibes hit different when Putin and Powell are both on the calendar.
Last week's Alaska summit ended with more questions than answers, Novo just turned their diabetes drug into a liver-fixing Swiss Army knife, and some PE firm decided to wake up Monday morning and casually drop $9 billion on an HR software company. Meanwhile, traders are sitting around like kids waiting for Christmas, except instead of Santa it's Jerome Powell at Jackson Hole.

Buckle up - it's going to be one of those weeks… let’s dive in.

🦆 Sitting duck energy

• 🇷🇺 Ukraine talks stir Wall Street nerves - Geopolitical vibes are getting spicy as Ukraine's president meets Trump for high-stakes peace talks. The market's barely moving, but traders are side-eyeing the Alaska summit like it holds the rate outlook.

• 📉 Markets flat ahead of Powell’s speech - S&P and Nasdaq opened slightly red as traders brace for Powell’s speech at Jackson Hole later this week. Everyone’s hoping for “pivot,” fearing “pause,” and expecting “nothing.”

• 💉 Novo Nordisk jumps 4% pre-market - Wegovy just scored FDA approval for treating MASH, a liver disease plaguing 22 million Americans. From fat burners to liver saviors, this drug is becoming Big Pharma's Swiss Army knife - and Wall Street can't get enough.

• 💼 Dayforce rockets 25% on buyout buzz - Thoma Bravo reportedly circling with PE cash to burn. The stock exploded on the news, because nothing says "strong fundamentals" like leveraged buyout speculation at 8:45 a.m.

• 🪙 Gemini files for IPO as "GEMI" - The Winklevoss twins are taking their crypto playground public. Nasdaq listing, "Super App" pitch, and full send energy. TradFi just got a new roommate.

💸 Trade Talk

Jackson Hole is basically Coachella for central bankers, and Powell's the reluctant headliner. He'll either stick to the script ("higher for longer") or fumble into a pivot hint - and traders are itching to decode every breath. Until then? Volatility's the only thing guaranteed.

^_[sponsored]

Options For Income From One Of America’s Most Well-Known Traders

Out of retirement to share his #1 strategy... Adam sold his trading company and thought he was done teaching about options after 20 years… Well, one strategy is working so well in this market, he agreed to share his strategy live in 1, free training. Get his 43-minute free training (and the recording) right here.

🧠 Big Brain Energy

About 22 million Americans have MASH liver disease…
And Novo Nordisk just turned their wonder drug into a one-stop shop for modern ailments. Weight loss, diabetes, liver disease... what's next, fixing your credit score?

🧨The Outrage Meter

Dayforce stock jumping 25% on buyout "reports" before most people had their morning coffee. PE firms really said "let's make Monday spicy" and dropped a rumor that sent algos into full FOMO mode.

^_[sponsored]

Learn the rhythm of the market [details inside]

Tom Busby, a market legend with over 40 years of experience has a strategy designed to help pinpoint the exact times of day when the market is most likely to make major moves. Imagine having a system that can help you find the exact rhythm of the market. Imagine having it at your fingertips every single time you enter a trade — so you can feel more confident knowing in an instant whether it’s a good time to get in. If you want to learn what makes the market tick (literally), go here now to see how this solution can help change the way you trade for the better.

🤔What Do You Think?

✌️ Thanks for vibing with us. Hit reply and let us know your take on today's market madness.

⚠️ WARNING: Market data is subject to rapid change. Verify current information before making trading decisions.

DISCLAIMER: Stocks and options trading have large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the stocks and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell stocks or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed in the linked report. The past performance of any trading system or methodology is not necessarily indicative of future results. All trades, patterns, charts, systems, etc., discussed in the linked report are for illustrative purposes only and not to be construed as specific advisory recommendations. Information contained in this correspondence is intended for informational purposes only and was obtained from sources believed to be reliable. Information is in no way guaranteed. No guarantee of any kind is implied or possible where projections of future conditions are attempted. For full disclaimer information, click here.